Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Grifols invertirá 160 millones en una nueva planta en Barcelona para fraccionar plasma. Las instalaciones, ubicadas junto a la planta de producción de Grifols en Parets del Vallès, comenzarán a construirse este mismo año y se estima que funcionen en 2030 https://t.co/hPctM0Ruzb
Grifols duplicará su capacidad de fraccionamiento de plasma en Europa con una nueva planta en Barcelona https://t.co/V5jjbFgqTR
Grifols marca máximos en Bolsa con alza del 14,8% desde enero de 2024 y esquiva impacto de aranceles de Trump https://t.co/p7vYhXhHbN
Grifols, the global healthcare company specializing in plasma-derived medicines, has announced a 160 million euro investment to build a new plasma fractionation plant in Barcelona, Spain. The new facility, located near its existing production site in Parets del Vallès, aims to double the company's plasma fractionation capacity in Europe. Construction is set to begin in 2025, with operations expected to commence by 2030. Despite the imposition of tariffs by the Trump administration, Grifols' stock has risen by 14.8% since January 2024, reflecting strong market performance amid these challenges.
